Лактионов Константин Павлович
Russian Cancer Research Center NN Blokhin · 92 works · 136 citations · h-index 6
Top works
- Role of Glutathione-Dependent Peroxidase in Regulation of Lipoperoxide Utilization in Malignant Tumors
- Matrix Metalloproteinases 2, 7, and 9 and Tissue Inhibitor of Metalloproteinases-1 in Tumors and Serum of Patients with Ovarian Neoplasms
- Insulin-Like Growth Factors (IGF) and IGF-Binding Proteins (IGFBP) in the Serum of Patients with Ovarian Tumors
- Prostaglandins E in primary tumor, metastases, and ascitic fluid of patients with ovarian cancer
- BREAST CANCER AND WOMAN’S REPRODUCTIVE FUNCTION (LITERATURE REVIEW)
- Clinical guidelines of the Russian Society of Oncomammologists for the prevention of breast cancer, differential diagnosis, treatment of precancerous and benign breast diseases
- Serum sFas, Leptin, and VEGF in Patients with Ovarian Cancer and Benign Tumors
- IMMUNE-MEDIATED ADVERSE EVENTS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS THERAPY
- Concentration of β-endorphin in blood plasma and cerebrospinal fluid during various types of anesthesia in the early postoperation period and in incurable oncological patients
- Relationship between the Expression of VEGF Signal Components and Matrix Metalloproteinases in Ovarian Tumors
- CLINICAL IMPLICATIONS OF INSULIN-LIKE GROWTH FACTORS (IGF) AND IGF-BINDING PROTEINS INVESTIGATION IN PATIENTS WITH OVARIAN NEOPLASMS
- MODERN CAPABILITIES OF BREAST PATHOLOGY DIAGNOSTICS
- [Assessment of oncologic risk of breast reconstruction simultaneous with surgery for breast cancer].
- Laparoscopic surgery in patients with cancer of the corpus uteri and metabolic syndrome
- A clinical case of 3-year highly efficient pembrolizamable therapy of metasatic lung adenocarcinoma
- REASONABILITY OF THE PRIMARY TUMOR REMOVAL IN METASTATIC BREAST CANCER PATIENTS AT INITIAL PRESENTATION
- Patient-Reported Outcomes in FLAURA2: Osimertinib with or without Chemotherapy in Patients with Previously Untreated EGFR-Mutated Advanced Non–Small Cell Lung Cancer
- PP-6-14 32P Relative Uptaking by a Tumor (32PRUT) is a Factor of Prognosis in Breast Cancer (BC) Patients
- IMMUNOPHENOTYPIC CHARACTERISTICS OF INFLAMMATORY BREAST CANCER
- Osimertinib for the first-line treatment of EGFR-positive non-small cell lung cancer